DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1AKYNZEO
02 1AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
03 1BARACLUDE
04 1CLARINEX
05 1CYCLOSPORINE
06 1REBETOL
07 1XYZAL
08 1ZOFRAN
01 120605
02 121277
03 121300
04 121546
05 121798
06 122157
07 165054
08 1210493
01 7No
02 1Yes
Drug : CYCLOSPORINE
Dosage Form : SOLUTION; ORAL
Application Number : 65054
Country : US
Patented : No
Drug : REBETOL
Dosage Form : SOLUTION; ORAL
Application Number : 21546
Country : US
Patented : No
Drug : AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 21277
Country : US
Patented : No
Drug : BARACLUDE
Dosage Form : SOLUTION; ORAL
Application Number : 21798
Country : US
Patented : No
LEVOCETIRIZINE DIHYDROCHLORIDE
Drug : XYZAL
Dosage Form : SOLUTION; ORAL
Application Number : 22157
Country : US
Patented : No
FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
Drug : AKYNZEO
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 210493
Country : US
Patented : Yes
Drug : CLARINEX
Dosage Form : SOLUTION; ORAL
Application Number : 21300
Country : US
Patented : No
Drug : ZOFRAN
Dosage Form : SOLUTION; ORAL
Application Number : 20605
Country : US
Patented : No
LOOKING FOR A SUPPLIER?